Laboratory Corporation of America Holdings (NYSE:LH) Q2 2023 Earnings Call Transcript

Glenn Eisenberg: Hi, Tim. What you’ll see is that consistent with what we’ve done before. So the same metrics that we provided for the two segments will continue. Obviously, Biopharma Laboratory Services now consists of the two versus the three businesses. But you’ll see in the enhanced disclosures that we provided, we continue to do a breakout of the individual businesses. And that from the segment standpoint we give guidance for their top line for the year. We provide, obviously in our remarks the trailing 12 months, which is really where we focus on book-to-bill and backlog and orders. But in the enhanced disclosures, we also provide that on a quarterly basis, so none of the changes from where we’ve been providing before.

Tim Daley: Alright. Great. And congrats, Chas. I look forward to working with you, Christen [ph].

Operator: Thank you. I would now like to hand the conference back over to Mr. Adam Schechter for closing remarks, please.

Adam Schechter: All right. Thank you, everybody for joining us today. And we really do look forward to sharing more with all of you at our Investor Day in September. So we look forward to that time. We wish you, in the meantime a very happy and healthy summer, and we’ll see you in September.

Operator: This concludes today’s conference call. Thank you for your participation. You may now disconnect. Everyone, have a wonderful day.